Half-year report · HY
7747.TEDINET S100XKTG
Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥71.3bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥120.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥24.4bn | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥17.4bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥24.1bn | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥29.6bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.8bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥24.8bn | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥16.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥17.2bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.7bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥17.3bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥195.9bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥193.2bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥190.1bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.2bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥41.8bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥158.7bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥151.4bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥158.9bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥53.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥54.2bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥53.5bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥37.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥17.8bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥40.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥18.3bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥957m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.4bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥18.6bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.1bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.9bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥64.56 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.92 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.14 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.6% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.9% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.2% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥8.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥8.3bn |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥4.0bn |
| Devicereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥16.9bn |
| Devicereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥8.6bn |
| Devicereportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥8.3bn |
| Devicereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥4.4bn |
| Medicalreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥62.7bn |
| Medicalreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥62.7bn |
| Medicalreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥23.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥79.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥71.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥28.3bn |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥3.6bn |
| Devicereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥13.0bn |
| Devicereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥5.7bn |
| Devicereportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Devicereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.5bn |
| Medicalreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| Medicalreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| Medicalreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥68.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥21.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 23084032 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.0870 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 19622000 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.0739 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 7778029 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0293 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 7200000 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0271 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 6982928 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0263 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 6690206 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0252 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 5822500 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0219 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 5306636 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0200 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 5075600 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0191 | |
| Number of shares held | InterimInstant | 125348831 | |
| Shareholding ratio | InterimInstant | 0.4724 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 7900 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 265295300 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 2652953 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 29100 | |
| Number of shares issued shares voting rights | InterimInstant | 265332300 | |
| Number of voting rights issued shares voting rights | InterimInstant | 2652953 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 7900 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 7900 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 7900 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 7900 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 54200000000 | JPY |
| Cash and deposits | InterimInstant | 53500000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 15767000000 | JPY |
| Notes and accounts receivable trade | InterimInstant | 16652000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 2026000000 | JPY |
| Electronically recorded monetary claims operating ca | InterimInstant | 2036000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 9408000000 | JPY |
| Merchandise and finished goods | InterimInstant | 9167000000 | JPY |
| Work in process | Prior1YearInstant | 8785000000 | JPY |
| Work in process | InterimInstant | 10201000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 6458000000 | JPY |
| Raw materials and supplies | InterimInstant | 7111000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |